Reproductive Outcome of Women with 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 41 of the 46 references it cites were found in a registry or an index.
Abstract
CONTEXT: Because many women with 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) carry at least one allele affected by a severe mutation of CYP21, they are at risk for giving birth to infants with classic adrenal hyperplasia (CAH). OBJECTIVE: Our objective was to determine the frequency of CAH and NCAH infants born to mothers with 21-OH-deficient NCAH. DESIGN AND SETTING: We conducted an international multicenter retrospective/prospective study. PATIENTS AND METHODS: The outcome of 203 pregnancies among 101 women with 21-OH-deficient NCAH was reviewed. The diagnosis of 21-OH-deficient NCAH was established by a basal or post-ACTH-stimulation 17-hydroxyprogesterone level of more than 10 ng/ml (30.3 nmol/liter). When possible, genotype analyses were performed to confirm CAH or NCAH in the offspring. RESULTS: Of the 203 pregnancies, 138 (68%) occurred before the mother's diagnosis of NCAH and 65 (32%) after the diagnosis. Spontaneous miscarriages occurred in 35 of 138 pregnancies (25.4%) before the maternal diagnosis of NCAH, and in only four of 65 pregnancies (6.2%) after the diagnosis (P < 0.002). Four (2.5%; 95% confidence interval, 0.7-6.2%) of the 162 live births were diagnosed with CAH. To date, 24 (14.8%; 95% confidence interval, 9.0-20.6%) children, 13 girls and 11 boys, have been diagnosed with NCAH. The distribution of NCAH children and their mothers varied significantly by ethnicity (P < 0.0001, for both). CONCLUSIONS: The risk of a mother with 21-OH-deficient NCAH for giving birth to a child affected with CAH is 2.5%; at least 14.8% of children born to these mothers have NCAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Both studies reported elevated miscarriage rates of ;25% in those not receiving GC and 6% in those exposed to GC.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, in two retrospective analyses of children born to women with NCCAH, the risk was higher, at 1.5% to 2.5% (234, 235).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Second, optimizing mineralocorticoid treatment appears to improve fertility SW and SV patients (365,591,663), but the exact mechanism remains unknown.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [663]
Experimental — accuracy not yet measuredIn the citing paper
“GC treatment was given to induce fertility in 23% (234) and 42% (235) of cases.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
In the citing paper
“Two retrospective studies of pregnancies among women with NCCAH found that the majority of pregnancies occurred prior to the mother's diagnosis of NCCAH (234, 235).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506 · cited 1×
“The degree of hirsutism was assessed using a modified FerrimanGallwey scoring method, and hirsutism was considered to be present when a score of at least 8 was evident (23, 24).”
MethodCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Self-citationCongenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Self-citationCongenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Self-citationHirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Self-citation(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
Department of Obstetrics and Gynecology
(2015) · Juntendo Medical Journal · doi:10.14789/jmj.61.322 · Cited by 365
Joint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
Azziz, R., Hincapie, L. A., Knochenhauer, E. S., Dewailly, D., Fox, L., & Boots, L. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00383-0 · Cited by 244 · cited 1×
“The endocrine diagnosis of 21-OH-deficient NCAH is based on markedly supranormal basal or ACTH-stimulated 17-hydroxyprogesterone (17-OHP) levels (3).”
BackgroundSelf-citationOkon, M. A., Laird, S. M., Tuckerman, E. M., & Li, T.-C. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00007-7 · Cited by 221 · cited 1×
“endometrial dysfunction has been noted (36).”
Pang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 191
Moran, C., Azziz, R., Carmina, E., Dewailly, D., Fruzzetti, F., Ibañez, L., Knochenhauer, E. S., Marcondes, J. A. M., Mendonca, B. B., Pignatelli, D., et al. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.108020 · Cited by 185 · cited 2×
“The protocol for evaluation of all these signs and symptoms were reported previously (20).”
BackgroundSelf-citationStikkelbroeck, N. M. M. L., Hoefsloot, L. H., de Wijs, I. J., Otten, B. J., Hermus, A. R. M. M., & Sistermans, E. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021681 · Cited by 171
Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency.
Feldman, S., Billaud, L., Thalabard, J. C., Raux-Demay, M. C., Mowszowicz, I., Kuttenn, F., & Mauvais-Jarvis, P. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1310999 · Cited by 155
Clinical and Biological Phenotypes in Late-Onset 21 Hydroxylase Deficiency
DEWAILLY, D., VANTYGHEM-HAUDIQUET, M.-C., SAINSARD, C., BUVAT, J., CAPPOEN, J. P., ARDAENS, K., RACADOT, A., LEFEBVRE, J., & FOSSATI, P. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-418 · Cited by 151
Self-citationDeneux, C., Tardy, V., Dib, A., Mornet, E., Billaud, L., Charron, D., Morel, Y., & Kuttenn, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.207 · Cited by 144
Tulppala, M., Stenman, U., Cacciatore, B., & Ylikorkala, O. (1993) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb12978.x · Cited by 144
SPEISER, P. W., LAFORGIA, N., KATO, K., PAREIRA, J., KHAN, R., YANG, S. Y., WHORWOOD, C., WHITE, P. C., ELIAS, S., SCHRIOCK, E., et al. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-838 · Cited by 128
Self-citation(1988) · PubMed · Cited by 110
Self-citationPremature pubarche as an indicator of how body weight influences the onset of adrenarche
Charkaluk, M., Trivin, C., & Brauner, R. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-003-1358-9 · Cited by 97 · cited 1×
“Precocious puberty and premature pubarche were considered when present in girls younger than 8 yr and boys younger than 9 yr (21, 22).”
BackgroundDolž;an, V, Sólyom, J., Fekete, G., Kovács, J., Rakosnikova, V, Votava, F., Lebl, J., Pribilincova, Z., Baumgartner-Parzer, S., Riedl, S., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01944 · Cited by 96
Bachega, T. A. S. S., Billerbeck, A. E. C., Marcondes, J. A. M., Madureira, G., Arnhold, I. J. P., & Mendonca, B. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00995.x · Cited by 90
Self-citationFIET, J., GUEUX, B., GOURMELEN, M., KUTTENN, F., VEXIAU, P., COUILLIN, P., PHAM-HUU-TRUNG, M.-T., VILLETTE, J.-M., RAUX-DEMAY, M., GALONS, H., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-659 · Cited by 90
Speiser, P. W., Knochenhauer, E. S., Dewailly, D., Fruzzetti, F., Marcondes, J. A. M., & Azziz, R. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3036 · Cited by 89
Self-citationCarriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism
Knochenhauer, E. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.479 · Cited by 81 · cited 1×
“Although we have previously reported that mothers who are obligate heterozygotes appear to be asymptomatic for the most part (32), it is possible that some CYP21 mutation carriers develop hyperandrogenic symptoms.”
BackgroundSelf-citationEarly Puberty: What Is Normal and When Is Treatment Indicated?
Ritzén, E. M. (2003) · Hormone Research in Paediatrics · doi:10.1159/000074497 · Cited by 67
Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia
Votava, F., Török, D., Kovács, J., Möslinger, D., Baumgartner-Parzer, S. M., Sólyom, J., Pribilincová, Z., Battelino, T., Lebl, J., Frisch, H., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01929 · Cited by 64
(1988) · PubMed · Cited by 59
Self-citationGenotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency
Weintrob, N., Brautbar, C., Pertzelan, A., Josefsberg, Z., Dickerman, Z., Kauschansky, A., Lilos, P., Peled, D., Phillip, M., & Israel, S. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430397 · Cited by 59
Self-citationKalmijn, M. (1993) · International Migration Review · doi:10.1177/019791839302700103 · Cited by 57 · cited 1×
“A likely explanation for the higher prevalence of affected offspring noted compared with calculated is the inherent tendency for individuals to intermarry within their ethnic subpopulation (14, 15), although this tendency lessens over generations among immigrants (14).”
BackgroundAZZIZ, R., BRADLEY, E., HUTH, J., BOOTS, L. R., PARKER, C. R., & ZACUR, H. A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1273 · Cited by 55
Self-citationWeintrob, N., Dickerman, Z., Sprecher, E., Galatzer, A., & Pertzelan, A. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360188 · Cited by 50
Self-citationSpeiser, P. (2001) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200101020-00003 · Cited by 34
Self-citationFiebert, M. S., Nugent, D., Hershberger, S. L., & Kasdan, M. (2004) · Psychological Reports · doi:10.2466/pr0.94.3c.1293-1300 · Cited by 11 · cited 1×
“A likely explanation for the higher prevalence of affected offspring noted compared with calculated is the inherent tendency for individuals to intermarry within their ethnic subpopulation (14, 15), although this tendency lessens over generations among immigrants (14).”
BackgroundGudmundsson, K., Majzoub, J. A., Bradwin, G., Mandel, S., & Rifai, N. (1999) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1999.12.6.895 · Cited by 8 · cited 1×
“Alternatively, falsenegative results may be evident in some affected children (29), especially those with milder types of CAH, including NCAH.”
BackgroundMolecular Diagnosis in the Congenital Adrenal Hyperplasias
Witchel, S. F. (1999) · The Endocrinologist · doi:10.1097/00019616-199905000-00006 · Cited by 4
Self-citationvan den Akker, E. S. A., Stikkelbroeck, M., Menheere, P. P. C. A., Roumen, F. J. M. E., & Otten, B. J. (2002) · PubMed · Cited by 2
Research works printed but not linked: 1
- Prader, 1954, Der genitalbefund beim pseudohermaphroditismus femininus des kongenitalen androgenitalen syndroms, Helvetica Paediatr Acta, 3, 231
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Spontaneous abortions occurred more frequently before treatment in two such studies of referred reproductive endocrinology clinic patients (224,225).”
BackgroundSelf-citationSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationAzziz, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002698 · Cited by 573
Self-citationCongenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationEscobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
“In addition, the prevalence of having a child with classic CAH is higher than predicted based on population frequency of mutation bearing CYP21A2 alleles (Moran et al., 2006).”
BackgroundSelf-citation
Metadata
- Authors
- Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., Mendonca, B. B., Bachega, T. A. S., Escobar-Morreale, H. F., Carmina, E., Fruzzetti, F., & Kelestimur, F.
- Affiliations
- Mexican Institute of Social Security (C.M.), 06725 Mexico City, Mexico
- Cedars-Sinai Medical Center (US)
- Schneider Children's Medical Center (IL)
- Children's Hospital of Pittsburgh (US)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Hospices Civils de Lyon (FR)
- Schneider Children's Hospital (US)
- Universidade do Porto (PT)
- Hospital Universitario Ramón y Cajal (ES)
- University of Palermo (IT)
- University of Pisa (IT)
- Erciyes University Medical School (F.K.), 3805 Kayseri, Turkey
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-09-01
- Volume
- 91
- Issue
- 9
- Pages
- 3451-3456
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2001112976
- Cited by
- 174
- References
- 46
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 9
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Funders
- Cedars-Sinai Medical Center
- National Institutes of Health
- U.S. Public Health Service (K24-D01346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- 21-hydroxylase deficiency, CYP21, pregnancy outcomes, miscarriage, prenatal diagnosis, ethnic differences, genotype analysis, 17-hydroxyprogesterone
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adult, Child, Preschool, Female, Genotype, Humans, Infant, Infant, Newborn, Male, Pregnancy, Prospective Studies, Retrospective Studies, Steroid 21-Hydroxylase, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.